Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124341882 | 12434188 | 2 | F | 2013 | 20160706 | 20160603 | 20160719 | EXP | US-ACORDA-ACO_124841_2016 | ACORDA | 61.23 | YR | F | Y | 41.72000 | KG | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124341882 | 12434188 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | U | U | 22250 | 10 | MG | TABLET | BID | ||||
| 124341882 | 12434188 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, QD | U | 0 | 325 | MG | QD | ||||||
| 124341882 | 12434188 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, QD | U | 0 | 81 | MG | QD | ||||||
| 124341882 | 12434188 | 4 | C | ENULOSE | LACTULOSE | 1 | Oral | 30 G, ONCE DAILY PRN | U | 0 | 30 | G | |||||||
| 124341882 | 12434188 | 5 | C | Momentum | PHENYLTOLOXAMINE | 1 | Oral | 30 ML, ONCE DAILY PRN | U | 0 | 30 | ML | |||||||
| 124341882 | 12434188 | 6 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 4 MG, EVERY 6 HOURS PRN | U | 0 | 4 | MG | |||||||
| 124341882 | 12434188 | 7 | C | Os-cal 500 + d | 2 | Oral | 1 DF, BID | U | 0 | 1 | DF | BID | |||||||
| 124341882 | 12434188 | 8 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 1000 IU, QD | U | 0 | 1000 | IU | QD | ||||||
| 124341882 | 12434188 | 9 | C | PROLIA | DENOSUMAB | 1 | Subcutaneous | 60 MG, EVERY 6 MONTHS | U | 0 | 60 | MG | |||||||
| 124341882 | 12434188 | 10 | C | XANAX | ALPRAZOLAM | 1 | Oral | 1 MG, QAM | U | 0 | 1 | MG | QD | ||||||
| 124341882 | 12434188 | 11 | C | XANAX | ALPRAZOLAM | 1 | Oral | 2 MG, HS | U | 0 | 2 | MG | QD | ||||||
| 124341882 | 12434188 | 12 | C | LIORESAL | BACLOFEN | 1 | Unknown | 10 MG, QID | U | 0 | 10 | MG | QID | ||||||
| 124341882 | 12434188 | 13 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 124341882 | 12434188 | 14 | C | SANCTURA | TROSPIUM CHLORIDE | 1 | Oral | 60 MG, QD | U | 0 | 60 | MG | QD | ||||||
| 124341882 | 12434188 | 15 | C | XENADERM | BALSAM PERU OILCASTOR OILTRYPSIN | 1 | APPLY TO AFFECTED AREA, BID | U | 0 | BID | |||||||||
| 124341882 | 12434188 | 16 | C | Silvasorb | SILVER OXIDE | 1 | APPLY TO AFFECTED AREA, QD | U | 0 | QD | |||||||||
| 124341882 | 12434188 | 17 | C | BACTRIM DS | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1 DF, BID | U | 0 | 1 | DF | BID | ||||||
| 124341882 | 12434188 | 18 | C | SILVADENE | SILVER SULFADIAZINE | 1 | Unknown | 1 %, APPLIED TO AFFECTED AREA QD | U | 0 | 1 | PCT | QD | ||||||
| 124341882 | 12434188 | 19 | C | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | 40 MG, 3X/WK | U | 0 | 40 | MG | TIW | ||||||
| 124341882 | 12434188 | 20 | C | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 124341882 | 12434188 | 21 | C | GARAMYCIN | GENTAMICIN SULFATE | 1 | Unknown | 0.1 %, APPLIED TO AFFECTED AREA QD | U | 0 | .1 | PCT | QD | ||||||
| 124341882 | 12434188 | 22 | C | Recovery protein shakes | 2 | UNK, TID | U | 0 | TID | ||||||||||
| 124341882 | 12434188 | 23 | C | VITAMIN C | ASCORBIC ACID | 1 | 500 MG, BID | U | 0 | 500 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124341882 | 12434188 | 1 | Multiple sclerosis |
| 124341882 | 12434188 | 2 | Product used for unknown indication |
| 124341882 | 12434188 | 4 | Product used for unknown indication |
| 124341882 | 12434188 | 5 | Product used for unknown indication |
| 124341882 | 12434188 | 6 | Product used for unknown indication |
| 124341882 | 12434188 | 7 | Product used for unknown indication |
| 124341882 | 12434188 | 8 | Product used for unknown indication |
| 124341882 | 12434188 | 9 | Product used for unknown indication |
| 124341882 | 12434188 | 10 | Product used for unknown indication |
| 124341882 | 12434188 | 12 | Product used for unknown indication |
| 124341882 | 12434188 | 13 | Product used for unknown indication |
| 124341882 | 12434188 | 14 | Product used for unknown indication |
| 124341882 | 12434188 | 15 | Product used for unknown indication |
| 124341882 | 12434188 | 16 | Product used for unknown indication |
| 124341882 | 12434188 | 17 | Product used for unknown indication |
| 124341882 | 12434188 | 18 | Product used for unknown indication |
| 124341882 | 12434188 | 19 | Product used for unknown indication |
| 124341882 | 12434188 | 21 | Product used for unknown indication |
| 124341882 | 12434188 | 22 | Product used for unknown indication |
| 124341882 | 12434188 | 23 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124341882 | 12434188 | HO |
| 124341882 | 12434188 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124341882 | 12434188 | Bladder dysfunction | |
| 124341882 | 12434188 | Choking | |
| 124341882 | 12434188 | Death | |
| 124341882 | 12434188 | Decubitus ulcer | |
| 124341882 | 12434188 | Dementia | |
| 124341882 | 12434188 | Fall | |
| 124341882 | 12434188 | Fibula fracture | |
| 124341882 | 12434188 | Muscle atrophy | |
| 124341882 | 12434188 | Syncope | |
| 124341882 | 12434188 | Tibia fracture | |
| 124341882 | 12434188 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |